Financial Year |
March 31 2023 |
Monetary Funds |
318,621,376.63 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
303,742.46 |
Accounts Receivable |
83,514,994.89 |
Advances to Suppliers |
151,797,596.92 |
Other Receivables |
6,430,929.57 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
177,299,010.16 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,929,495.19 |
Total Current Assets |
739,897,145.82 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
4,975,884.83 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
811,915.99 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
4,714,781.09 |
Deferred Income Tax Assets |
21,485,101.51 |
Other Non-Current Assets |
2,612,827.67 |
Sub-Total of Non-Current Assets |
56,040,494.84 |
Total Assets |
795,937,640.66 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
92,164,275.64 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
5,423,093.12 |
Taxes Payable |
6,300,266.22 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,891,623.31 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,205,559.84 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
118,837,181.39 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,360,000.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
14,867,675.07 |
Total Liabilities |
133,704,856.46 |
Paid-In Capital(Or Share Stock) |
400,309,400.00 |
Capital Surplus |
19,380,782.45 |
Surplus Reserve |
23,913,524.58 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
218,629,077.17 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
662,232,784.20 |
Owner's Equity(Stockholder's Equity) |
662,232,784.20 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
795,937,640.66 |